Leen Kawas - Net Worth and Insider Trading
Leen Kawas Net Worth
The estimated net worth of Leen Kawas is at least $1 Million dollars as of 2024-11-05. Leen Kawas is the 10% Owner of Eiger BioPharmaceuticals Inc and owns about 146,381 shares of Eiger BioPharmaceuticals Inc (EIGRQ) stock worth over $1 Million. Details can be seen in Leen Kawas's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Leen Kawas has not made any transactions after 2023-10-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Leen Kawas
Leen Kawas Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Leen Kawas owns 2 companies in total, including Athira Pharma Inc (ATHA) , and Eiger BioPharmaceuticals Inc (EIGRQ) .
Click here to see the complete history of Leen Kawas’s form 4 insider trades.
Insider Ownership Summary of Leen Kawas
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATHA | Athira Pharma Inc | 2020-09-17 | director & 10 percent owner & President & CEO |
| EIGRQ | Eiger BioPharmaceuticals Inc | 2023-10-31 | 10 percent owner |
Leen Kawas Latest Holdings Summary
Leen Kawas currently owns a total of 1 stock. Leen Kawas owns 146,381 shares of Eiger BioPharmaceuticals Inc (EIGRQ) as of October 31, 2023, with a value of $1 Million.
Latest Holdings of Leen Kawas
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EIGRQ | Eiger BioPharmaceuticals Inc | 2023-10-31 | 146,381 | 8.50 | 1,244,239 |
Holding Weightings of Leen Kawas
Leen Kawas Form 4 Trading Tracker
According to the SEC Form 4 filings, Leen Kawas has made a total of 1 transactions in Eiger BioPharmaceuticals Inc (EIGRQ) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Eiger BioPharmaceuticals Inc is the acquisition of 811 shares on October 31, 2023, which cost Leen Kawas around $6,326.
Insider Trading History of Leen Kawas
- 1
Leen Kawas Trading Performance
GuruFocus tracks the stock performance after each of Leen Kawas's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Leen Kawas is -12.01%. GuruFocus also compares Leen Kawas's trading performance to market benchmark return within the same time period. The performance of stocks bought by Leen Kawas within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Leen Kawas's insider trading performs compared to the benchmark.
Performance of Leen Kawas
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 30.27 |  | | | | |
| Relative Return to S&P 500(%) | 20.71 | | | | | |
Leen Kawas Ownership Network
Ownership Network List of Leen Kawas
Ownership Network Relation of Leen Kawas
Leen Kawas Owned Company Details
What does Athira Pharma Inc do?
Who are the key executives at Athira Pharma Inc?
Leen Kawas is the director & 10 percent owner & President & CEO of Athira Pharma Inc. Other key executives at Athira Pharma Inc include See Below Andrew Gengos , Chief Operating Officer Mark James Litton , and Vice President of Discovery Kevin Church .
Athira Pharma Inc (ATHA) Insider Trades Summary
Over the past 18 months, Leen Kawas made no insider transaction in Athira Pharma Inc (ATHA). Other recent insider transactions involving Athira Pharma Inc (ATHA) include a net purchase of 77,532 shares made by Andrew Gengos , a net sale of 14,672 shares made by Mark James Litton , and a net sale of 7,349 shares made by Rachel Lenington .
In summary, during the past 3 months, insiders sold 13,879 shares of Athira Pharma Inc (ATHA) in total and bought 0 shares, with a net sale of 13,879 shares. During the past 18 months, 36,787 shares of Athira Pharma Inc (ATHA) were sold and 728,098 shares were bought by its insiders, resulting in a net purchase of 691,311 shares.
Athira Pharma Inc (ATHA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Athira Pharma Inc Insider Transactions
Leen Kawas Mailing Address
Above is the net worth, insider trading, and ownership report for Leen Kawas. You might contact Leen Kawas via mailing address: 4000 Mason Road, Suite 300, Box 352141, Seattle Wa 98195-2141.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
